We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-1.34%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.17B
AUM Growth
+$393M
Cap. Flow
+$459M
Cap. Flow %
39.32%
Top 10 Hldgs %
24.34%
Holding
4,355
New
842
Increased
1,505
Reduced
871
Closed
1,089

Sector Composition

Rank Sector Weight
1 Financials 6.75%
2 Industrials 5.87%
3 Consumer Discretionary 5.39%
4 Technology 4.75%
5 Healthcare 3.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIRE
2476
DELISTED
Sisecam Resources LP
SIRE
$10K ﹤0.01%
+372
New +$10.1K
GPL
2477
DELISTED
Great Panther Mining Limited
GPL
$10K ﹤0.01%
821
+314
+62% +$3.9K
EPAY
2478
DELISTED
Bottomline Technologies Inc
EPAY
$10K ﹤0.01%
+260
New +$9.7K
TLGT
2479
DELISTED
Teligent, Inc
TLGT
$10K ﹤0.01%
303
-1,351
-82% -$43K
KIN
2480
DELISTED
Kindred Biosciences, Inc.
KIN
$10K ﹤0.01%
+1,119
New +$9.82K
CLCT
2481
DELISTED
Collectors Universe
CLCT
$10K ﹤0.01%
609
-1,487
-71% -$31.2K
FBM
2482
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
$10K ﹤0.01%
700
-4,931
-88% -$73.9K
AKAO
2483
DELISTED
Achaogen Inc
AKAO
$10K ﹤0.01%
754
-17,894
-96% -$203K
CBK
2484
DELISTED
Christopher & Banks Corporation
CBK
$10K ﹤0.01%
8,518
+5,101
+149% +$5.93K
TNTR
2485
DELISTED
Tintri, Inc. Common Stock
TNTR
$10K ﹤0.01%
+5,820
New +$29.4K
PHIIK
2486
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$10K ﹤0.01%
991
-962
-49% -$10.6K
GCI
2487
DELISTED
Gannett Co., Inc
GCI
$10K ﹤0.01%
+1,000
New +$10.9K
APLS
2488
DELISTED
Apellis Pharmaceuticals
APLS
$9K ﹤0.01%
+405
New +$7.96K
AVAL icon
2489
Grupo Aval
AVAL
$6.27B
$9K ﹤0.01%
1,109
-664
-37% -$5.83K
BIB icon
2490
ProShares Ultra NASDAQ Biotechnology
BIB
$88.2M
$9K ﹤0.01%
161
-47,865
-100% -$2.87M
COKE icon
2491
Coca-Cola Consolidated
COKE
$12.4B
$9K ﹤0.01%
500
-630
-56% -$12K
CORT icon
2492
Corcept Therapeutics
CORT
$12.3B
$9K ﹤0.01%
+533
New +$9.88K
CTLP
2493
DELISTED
Cantaloupe
CTLP
$9K ﹤0.01%
+1,024
New +$9.15K
GNL icon
2494
Global Net Lease
GNL
$1.95B
$9K ﹤0.01%
+518
New +$9.1K
B
2495
Barrick Mining
B
$68.5B
$9K ﹤0.01%
694
-78,001
-99% -$1.04M
HPQ icon
2496
HP
HPQ
$27.3B
$9K ﹤0.01%
400
-27,374
-99% -$618K
IEF icon
2497
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$9K ﹤0.01%
84
+35
+71% +$3.6K
LXU icon
2498
LSB Industries
LXU
$726M
$9K ﹤0.01%
+1,921
New +$11.6K
LYG icon
2499
Lloyds Banking Group
LYG
$88.8B
$9K ﹤0.01%
2,400
-64,726
-96% -$251K
MRIN
2500
DELISTED
Marin Software
MRIN
$9K ﹤0.01%
+215
New +$11.3K

Similar funds

Tower Research Capital (TRC)'s Q1 2018 Portfolio in Review

As of Q1 2018, Tower Research Capital (TRC) held 4,355 positions worth $1.17B, up 51% from $775M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $459M of net new capital in Q1 2018, opening 842 new positions and adding to 1,505 existing holdings. Its largest new stake was iShares MSCI EAFE ETF: 717,758 shares worth $50M.

By sector, the portfolio is most concentrated in Financials at 6.7% of assets, down from 11% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $21M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2018 buy was iShares MSCI EAFE ETF: 717,758 shares worth $50M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q1 2018, an estimated $69.7M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $21M.
  • Tower Research Capital (TRC) fully exited Berkshire Hathaway Class B in Q1 2018, selling an estimated $7.94M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $1.17B portfolio in Q1 2018.
  • Tower Research Capital (TRC) opened 842 new positions and closed 1,089 in Q1 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 51% quarter-over-quarter to $1.17B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2018, filed 15 May 2018.